New strength of Asacol MR

A new higher strength of Asacol (mesalazine) MR tablets has launched.

The 800mg MR tablets, indicated for mild to moderate acute exacerbations of ulcerative colitis and maintenance of remission of ulcerative colitis and Crohn’s ileo-colitis, allow twice-daily dosing

View Asacol MR drug record

Further information: Procter & Gamble

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more